InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the detailed record of transactions filed by Brennan Aoife, Director. Insider active across 2 companies, notably FIBROGEN INC. Cumulatively, 6 filings have been published. Total volume traded: €20k. The latest transaction was disclosed on 16 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations6 total
015,777 shares0
Common Stock
SEC:0001209191-22-038603:0·
€19,8208,894 shares@ €2.22840.15% mcap100.0% of flow
Common Stock
SEC:0000899243-22-014110:0·
0106,920 shares0
Common Stock
SEC:0000899243-22-005213·
0106,920 shares0
Common Stock
SEC:0000899243-22-005213:0·
04,700 shares0
Common Stock
SEC:0001209191-21-036668·
04,700 shares0
Common Stock
SEC:0001209191-21-036668:0·
6 of 6 declarations
About Brennan Aoife
Aoife Brennan is a Director at FibroGen Inc and Synlogic, Inc. She brings valuable expertise in the biotechnology and healthcare sectors. As a board member, Aoife plays a key role in the governance of the companies, participating in strategic decision-making that influences their direction and performance. Her experience in the sector enables her to contribute to discussions on innovation and the development of new treatments, thereby strengthening the companies' market position.
